Bone Health Matters: Why is it important to have Early Osteoporosis (Bone Loss) Screening?

By Dr. Magdalena - Family Medical Practice Vietnam

Osteoporosis is often called a silent disease. Bone loss progresses slowly and without symptoms, and many people only become aware of the problem after suffering a fracture. Among these, vertebral fractures — fractures of the spine — are particularly common, frequently under-diagnosed, and can occur even without a clear traumatic event. Early detection of osteoporosis through bone density testing allows timely intervention, significantly reducing the risk of fractures, chronic pain, disability, and loss of independence. This is especially important for women of Asian ethnicity, who have a higher risk of vertebral fractures due to specific biological and structural factors.

What Is Osteoporosis?

Osteoporosis is a condition characterized by reduced bone strength, making bones more fragile and prone to fractures. Bone strength depends not only on bone density but also on bone microarchitecture and quality. Fractures related to osteoporosis typically occur after minimal trauma, such as a fall from standing height or sometimes without any noticeable injury at all.

Who should be screened for Osteoporosis?

1. Women ≥ 65 years and Men ≥ 70  

2. Women 50- 65 years with risk factors:

   • History of fragility fracture (hip, wrist, humerus, pelvis, vertebral in the context of low impact trauma)

   • Low body weight (BMI < 20–21) or history of malnutrition or anorexia-bulimia

   • Chronic glucocorticoid use (≥ 5 mg prednisone daily for ≥ 3 months)

   • Current Smoking

   • Alcohol intake > 3 drinks/day

   • Medical conditions that increase bone loss: rheumatoid arthritis, lupus, type 1 diabetes, hyperthyroidism, hyperparathyroidism, chronic liver disease, malabsorption syndromes, inflammatory bowel disease, COPD, chronic kidney disease, HIV, history of long-term amenorrea (current or past) etc.

   • Parental history of hip fracture (1^st grade Relative)

   • Chronic use of: aromatase inhibitors (breast cancer drugs), anticonvulsants, PPI, IRSS, Tiazolidinediones, high prolactine related antipsicotics, calcineurine inhibitors, tenofovir  

3. Women with Premature ovarian insufficiency

4. Men 50–69 years with risk factors (similar to women)

How Do We Screen for Osteoporosis?

1. Bone Densitometry (DXA)

   Dual-energy X-ray absorptiometry (DXA) is the gold standard test for diagnosing osteoporosis. It is painless, fast, and uses very low radiation (10 times lower compared with an X ray).

2. Laboratory Evaluation

   Blood and urine tests may be used to rule out secondary causes of bone loss, including vitamin D deficiency, thyroid dysfunction, calcium imbalance, or inflammatory disease.

Why Early Diagnosis and Treatment Matter

The benefits of early detection are substantial:

• Fracture Prevention: Medications approved for osteoporosis have been shown in large clinical trials to reduce vertebral, hip, and non-vertebral fractures.

• Preservation of Independence: Preventing fractures means maintaining mobility, posture, and quality of life.

• A Critical Window of Opportunity: The risk of a second fracture is highest in the first 1–2 years after an initial fracture. Early treatment during this period significantly lowers future fracture risk.

Asian Women are at Higher Risk of Vertebral Fractures

Research consistently shows that women of Asian ethnicity experience a higher prevalence of vertebral fractures, even when bone density measurements appear similar or only mildly reduced compared to other populations.

This increased risk is explained by several factors:

1. Lower body size and bone geometry: Asian women tend to have: Smaller skeletal size, lower body mass index, different vertebral shape and bone geometry. Smaller vertebrae may tolerate less mechanical stress, increasing fracture susceptibility.

2. Bone micro architecture differences: Bone strength is not determined by density alone. Studies using advanced imaging show that differences in trabecular structure and cortical thickness may contribute to increased fragility, even when standard bone density values appear reassuring.

3. Nutritional and Lifestyle Factors: Lower lifetime intake of calcium, vitamin D deficiency, reduced sun exposure, and lower engagement in weight-bearing exercise may further impact bone health.

4. Underestimation of Risk by Standard Tools: Common risk calculators and bone density thresholds may underestimate fracture risk in Asian populations, particularly for vertebral fractures. This highlights the importance of individualized assessment rather than relying on bone density numbers alone.

Treatment Is More Than Medication

While medications are effective, comprehensive bone care also includes:

• Weight-bearing and muscle-strengthening exercise

• Adequate calcium and vitamin D intake

• Fall prevention strategies

• Avoidance of smoking and excessive alcohol

• Regular follow-up and monitoring

Osteoporosis is preventable, detectable, and treatable. Vertebral fractures do not have to be an inevitable consequence of aging.

For both women and men, a proactive bone health assessment can make a meaningful difference. A simple bone density test can help identify silent risk and open the door to effective prevention.

Strong bones support an active, independent life — and it’s never too early to start protecting them.

Dr. Magdalena Ida Cavalieri is a rheumatologist specializing in the diagnosis and treatment of joint, muscle and autoimmune conditions. With over 10 years of clinical experience in Rheumatology, she provides comprehensive care for patients with arthritis, osteoporosis, connective-tissue disorders and other musculoskeletal concerns. Dr. Cavalieri is fluent in English and Spanish, offering patient-centered consultations and personalized treatment plans to support long-term bone and joint health.

FMP Healthcare Group operates medical centers in major cities including HCMC, Ha Noi and Đa Nang, offering consultations with international doctors, check-up centres and emergency ambulance services.

Visit FMP Thao Dien in Ho Chi Minh City to consult with Dr. Magdalena Ida Cavalieri.

To book an appointment, please call (028) 3744 2000 (FMP - Thao Dien), or email d2.reception@vietnammedicalpractice.com